DRTB

CHA

Tag: DRTB

From innovation to action: MSF shares 25 years of lessons learned in tackling Drug-Resistant TB

January 22, 2025, New Delhi: Médecins Sans Frontières (MSF)/Doctors Without Borders, in partnership with the National TB Elimination Program (NTEP) and the Brihanmumbai Municipal Corporation (BMC), hosted a panel discussion today to mark the culmination of 25 years of continuous...

Read more

Médecins Sans Frontières Wraps Up Tuberculosis Project in Dushanbe, Tajikistan: A Timeline of Achievements

Dushanbe, Tajikistan – As Médecins Sans Frontières (MSF) concludes its tuberculosis (TB) project in Dushanbe, Tajikistan, after 13 years of collaboration with the Ministry of Health and Social Protection of Population, we reflect on the programme's journey.MSF’s work in Dushanbe...

Read more

Deepak Shegar: Battling DR-TB with resilience and dreams

"When I recover, I want to play cricket," says Deepak Shegar, a 23-year-old whose aspirations extend far beyond his battle with drug-resistant tuberculosis (DR-TB). With dreams of a career in the garment industry, a love for cricket, and a desire...

Read more

Myanmar: I have defeated TB and I wish the same for other patients

Multi-drug resistant tuberculosis is one of the most complex types of tuberculosis you can get. As opposed to drug-sensitive, which responds well to the medication, multi-drug resistant tuberculosis, by its very name, is resistant to some of the drugs used...

Read more

Namrata’s Journey: Triumph Over Drug-Resistant Tuberculosis

Namrata's story is a testament to the timeless principle that consistency is crucial. Her disciplined approach to maintaining a routine, embracing a healthy lifestyle, and adhering to medication regimens demonstrates that even conditions like drug-resistant tuberculosis (DR-TB) can be overcome....

Read more

Patient Stories: Ensuring recovery through timely, accurate drug-resistant tuberculosis testing

Ahmad, 11, from Tatlay Aali, a town in Gujranwala district, Pakistan, was diagnosed with tuberculosis (TB) when he was just five years old. "We’d never heard about this disease, nobody from our family ever had it. At the same time,...

Read more

Landmark clinical trial redefines multidrug-resistant tuberculosis Treatment options

endTB Clinical Trial Offers Multiple New Shortened Drug Regimens to Treat Adults and Children with Multidrug-Resistant Tuberculosis Paris, France; November 15, 2023 – Clinical trial results presented for the first time today at the Union World Conference on Lung Health...

Read more

Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need

TB is curable but remains the world’s leading infectious disease killer 12 September 2023, Geneva/New York – Next week, world leaders meet for the second-ever global tuberculosis (TB) High-Level Meeting at the United Nations (UN) in New York, to endorse...

Read more

MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics

MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics. Recent deal offering controlled generics access in limited countries does not go...

Read more

From Nhlangano to the Future, MSF’s legacy in Shiselweni region: 5 key facts about MSF in Eswatini

As Médecins Sans Frontières/Doctors Without Borders (MSF) prepares to leave the Shiselweni region after 16 years of work, its project in Nhlangano draws to a close. However, to ensure the continued success of the Shiselweni HIV & tuberculosis (TB) programme,...

Read more

MSF applauds Indian Patent Office’s rejection of Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug

Mumbai, 23 March 2023 – Today, the 2019 patent challenge by two tuberculosis (TB) survivors, Nandita Venkatesan and Phumeza Tisile, was successful: the Indian Patent Office rejected the US pharmaceutical corporation Johnson & Johnson’s (J&J) attempt to extend its monopoly...

Read more

Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB

Delhi, 22 March 2023 - Médecins Sans Frontières/Doctors Without Borders (MSF) called on governments and donors today to speed up access to new, shorter, safer and more effective treatments* for drug-resistant tuberculosis (DR-TB), as well as the diagnostic tests needed...

Read more
Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons